Ribosome display or mRNA display method with selection for increased stability of the protein

Details for Australian Patent Application No. 2006204424 (hide)

Owner Cambridge Antibody Technology Limited

Inventors Buchanan, Andrew; Jermutus, Lutz

Agent Spruson & Ferguson

Pub. Number AU-B-2006204424

PCT Pub. Number WO2006/072773

Priority 0500099.7 05.01.05 GB; 60/642,209 05.01.05 US

Filing date 5 January 2006

Wipo publication date 13 July 2006

Acceptance publication date 8 September 2011

International Classifications

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

Event Publications

9 August 2007 PCT application entered the National Phase

  PCT publication WO2006/072773 Priority application(s): WO2006/072773

8 September 2011 Application Accepted

  Published as AU-B-2006204424

19 January 2012 Standard Patent Sealed

10 May 2012 Alteration of Name

  The name of the patentee has been altered to MedImmune Limited 2007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006204435-Methods of separating feed materials using a magnetic roll separator

2006204405-N- (heteroaryl) - 1H-indole-2-carboxamide derivatives and their use as vanilloid TRPV1 receptor ligands